Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%

Symptomatic remission · Patients with quiescent ulcerative colitis

Rectal 5‐ASA may leads to higher symptomatic remission compared with placebo (low certainty).

1 finding from 1 review

Rectal 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2012 · Cochrane Headline outcomes only
RR 2.22 [1.26, 3.9]
4 studies · 301 participants
Low

Symptomatic remission · Patients with quiescent ulcerative colitis

Rectal 5‐ASA showed no clear difference in symptomatic remission compared with oral 5‐ASA (low certainty).

1 finding from 1 review

Rectal 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2012 · Cochrane Headline outcomes only
RR 1.24 [0.92, 1.66]
2 studies · 69 participants
Low

Endoscopic remission · Patients with quiescent ulcerative colitis

Rectal 5‐ASA showed no clear difference in endoscopic remission compared with oral 5‐ASA (low certainty).

1 finding from 1 review

Rectal 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis 2012 · Cochrane Headline outcomes only
RR 1.14 [0.9, 1.45]
2 studies · 91 participants
Low